Abbott Laboratories share price logo

Abbott Laboratories Share Price

NYSE: ABT

Large Cap

$103.97

-0.60

(-0.57%)

as on

Abbott Laboratories Stock Performance

as on March 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $103.68
    $105.46
    downward going graph

    0.28%

    Downside

    1.43%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $102.41
    $139.06
    downward going graph

    1.50%

    Downside

    33.75%

    Upside

    downward going graph

Abbott Laboratories share price movements today

Previous Close
$104.57
Open
$104.86
Volume
10.8M
Day's Low - High
$103.68 - $105.46
52 Week Low - High
$102.41 - $139.06

Abbott Laboratories Historical Returns

1 Month Return
-10.62 %
3 Month Return
-16.7 %
1 Year Return
-20.51 %
3 Year Return
+ 7.08 %
5 Year Return
-14.81 %

Abbott Laboratories Stock Fundamentals & Key Indicators

Check Abbott Laboratories market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$181.7B

EPS (TTM)

5.4733

Dividend Yield

1.90%

Quarterly Earnings Growth YOY

-0.81%

PE Ratio (TTM)

28.11

Industry PE ratio

17.836410256410257

PEG Ratio

1.5219

EBITDA

12.0B

Revenue (TTM)

44.3B

Profit Margin

14.72%

Return On Equity TTM

12.96%

Abbott Laboratories Stock Valuation

Track how Abbott Laboratories P/E has moved over time to understand its valuation trends.

Abbott Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (18.93x)

September 30, 2022

Industry (17.84x)

March 28, 2026

Today (28.11x)

March 28, 2026

Highest (30.52x)

June 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 28.11x

Abbott Laboratories vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abbott Laboratories with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Abbott Laboratories image
Abbott Laboratories
BUY$181.7B-14.81%28.1114.72%
Johnson & Johnson image
Johnson & Johnson
BUY$576.5B45.79%21.6928.46%
Pfizer Inc. image
Pfizer Inc.
HOLD$156.8B-25.41%20.2712.42%

Stock Returns calculator for Abbott Laboratories Stock including INR - Dollar returns

The Abbott Laboratories stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Abbott Laboratories investment value today

Current value as on today

₹90,104

Returns

₹9,896

(-9.9%)

Returns from Abbott Laboratories Stock

₹20,524 (-20.52%)

Dollar Returns*

₹10,628 (+10.63%)

Analyst Recommendation on Abbott Laboratories Stock

Based on 29 analysts

BUY

75.86%

Buy

24.14%

Hold

0.00%

Sell

Based on 29 analysts, 75.86% of analysts recommend a 'BUY' rating for Abbott Laboratories. Average target price of $132.64

Abbott Laboratories Share Price Target

Get share price movements and forecasts by analysts on Abbott Laboratories.

What analysts predicted

21.61%UPSIDE

Target Price

$132.64

Current Price

$103.97

Analyzed by

29 Analysts

Target

$132.64

Abbott Laboratories target price $132.64, a slight upside of 21.61% compared to current price of $103.97. According to 29 analysts rating.

Abbott Laboratories Stock’s Investor Sentiment and Interest

Investment in Abbott Laboratories Shares on INDmoney has dropped by -27.48% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-27.48% versus previous 30 day period

Search interest for Abbott Laboratories Stock has decreased by -36% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-36% versus previous 30 day period

Abbott Laboratories Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
10,143
10,241
9,964
10,377
10,635
10,974
10,358
11,142
11,369
11,459
Gross Profit
5,034
5,258
5,022
5,305
5,426
5,598
5,444
6,288
6,338
6,537
Operating Income
1,678
1,864
1,385
1,686
1,818
1,990
1,688
2,052
2,057
2,251
EBITDA
2,643
2,843
2,358
2,580
2,907
2,989
2,668
3,048
3,092
2,822
Interest Expense
148
235
117
168
166
152
134
121
44
42
Depreciation
496
813
805
805
801
807
756
777
791
792
Income Before Tax
1,671
1,795
1,436
1,607
1,940
2,030
1,778
2,150
2,180
2,358
Income Tax Expense
235
201
211
305
294
-7,199
453
371
536
582
Net Income
1,436
1,594
1,225
1,302
1,646
9,229
1,325
1,779
1,644
1,776
Net Profit Margin
14.16%
15.56%
12.29%
12.55%
15.48%
84.10%
12.79%
15.97%
14.46%
15.50%

Abbott Laboratories Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
20,853
27,390
30,578
31,904
34,608
43,075
43,653
40,109
41,950
44,328
Gross Profit
11,244
13,066
15,823
16,693
17,377
23,214
22,323
20,037
21,325
24,607
Operating Income
3,249
1,972
3,844
4,591
5,291
9,200
8,362
6,435
6,825
8,048
EBITDA
3,070
6,132
6,880
7,909
9,003
12,159
11,888
10,605
10,834
11,553
Interest Expense
304
880
729
818
708
410
315
698
603
341
Depreciation
-
3,021
3,278
3,014
3,327
2,047
2,013
3,237
3,218
3,116
Income Before Tax
1,413
2,231
2,873
4,077
4,968
8,211
8,306
6,664
7,013
8,466
Income Tax Expense
350
1,878
539
390
497
1,140
1,373
941
-6,389
1,942
Net Income
1,400
477
2,368
3,687
4,495
7,071
6,933
5,723
13,402
6,524
Net Profit Margin
6.71%
1.74%
7.74%
11.56%
12.99%
16.42%
15.88%
14.27%
31.95%
14.72%

Abbott Laboratories Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
1,594
1,225
1,302
1,646
9,229
1,325
1,779
1,644
1,776
Operating Cash Flow
3,038
1,025
1,960
2,705
2,868
1,417
2,047
2,787
3,315
Investing Cash Flow
-824
-425
-453
-594
-866
-470
-582
-457
-913
Financing Cash Flow
-2,052
-1,176
-791
-1,576
-1,861
-2,055
-1,097
-1,760
-1,397
Change in Cash
187
-612
703
571
58
-1,084
419
560
1,011

Abbott Laboratories Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
477
2,368
3,687
4,495
7,071
6,933
5,723
13,402
6,524
Operating Cash Flow
5,570
6,300
6,136
7,901
10,533
9,581
7,261
8,558
9,566
Investing Cash Flow
-9,618
-1,356
-1,815
-2,215
-2,008
-1,740
-3,133
-2,338
-2,422
Financing Cash Flow
-5,281
-10,391
-4,289
-2,779
-5,494
-7,636
-7,091
-5,404
-6,309
Change in Cash
-9,213
-5,563
16
2,978
2,961
83
-2,986
720
906

Mutual Funds that own Abbott Laboratories Stock

Check out the Mutual Funds with significant holdings in Abbott Laboratories.

Global Institutional Holdings in Abbott Laboratories

Funds
Holdings
Charles Schwab Investment Management Inc
0.76%
Amvescap Plc.
0.8%
Capital Research Global Investors
2.23%
Vanguard Group Inc
10.1%
J Stern & Co LLP
2.26%
See all

Abbott Laboratories News & Key Events

    Insights on Abbott Laboratories

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Abbott Laboratories has seen a positive trend in its net profit over the last two quarters. The net profit increased from $1.64 billion to $1.77 billion, reflecting an average growth of 7.4% per quarter.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Abbott Laboratories has shown strong revenue growth over the last four quarters. The revenue increased from $10.35 billion to $11.45 billion, reflecting an average growth rate of 3.3% each quarter.

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Johnson & Johnson has given 58.4% return, outperforming this stock by 51.3%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Johnson & Johnson has given 46.9% return, outperforming this stock by 67.4%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 1 month, ABT stock has moved down by -10.6%

    About Abbott Laboratories

    "Abbott Laboratories, headquartered in Chicago, Illinois, was founded in 1888 by a physician named Dr Wallace Calvin. His purpose was to improve people's well-being and help them reach their full potential at different stages of their lives. Founded as a drug formulation company, today, Abbott Laboratories is a worldwide leader in healthcare, medical devices, nutritional products, and pharmaceutical drugs. Even though it reached the shores of India a century ago, it is still regarded as one of the largest healthcare product companies. With a focus on cardiovascular, diagnostic, diabetes, and neuromodulation products, some of its popular brands include Pedialyte, Glucerna, Similac, Ensure, and iStat. Abbott opened its first international office in London in 1907, and currently operates in over 160 countries. Its growth is also a result of strategic acquisitions. Abbott’s recent acquisitions include Kalo Pharma International in 2014, which doubled its brand generic drug portfolio. It acquired Tendyne in 2015 and along with it the company’s minimally invasive mitral valve replacement therapies. Another gem in the crown is the acquisition of Alere in 2016, which gave Abbott access to the largest mail-order diabetic supplier, Arriva Medical. Along with strategic acquisitions, the company is dedicated to gaining a strong competitive advantage. With the onset of COVID-19, the company has developed various antibody tests that have been granted emergency-use authorization. According to Forbes, Abbott Laboratories' fast and low-cost testing methods have expedited the detection of COVID-19 virus. For its 2030 sustainability plan, the company is gearing up to introduce revolutionary products such as BinaxNOW, a COVID-19 test, and FreeStyle Libre, an innovative glucose monitoring device. Abbott’s future plans are centred around providing cutting-edge technologies at affordable prices to even the most vulnerable sections of society. Currently Abbott Laboratories has a market cap of $181.71 Billion. It has a P.E ratio of 28.11. The shares of Abbott Laboratories are trading at {current share price in dollars (in INR)}."
    OrganisationAbbott Laboratories
    Headquarters100 Abbott Park Road, Lake County, IL, United States, 60064-6400
    IndustryHealth Technology
    CEOMr. Robert B. Ford
    E-voting on sharesClick here to vote

    Key Management of Abbott Laboratories

    Name

    Title

    Mr. Michael Comilla

    Vice President of Investor Relations.

    Erica L. Battaglia

    VP and Chief Ethics & Compliance Officer

    Ms. Elizabeth Cushman

    Executive VP, General Counsel & Secretary

    Mr. Robert B. Ford

    Chairman, President & CEO

    Mr. Philip P. Boudreau

    CFO & Executive VP of Finance

    Mr. Christopher J. Scoggins

    Executive Vice President of Diabetes Care

    Ms. Lisa D. Earnhardt

    Executive VP & Group President of Medical Devices

    Ms. Sabina Ewing

    Senior VP of Business & Technology Services and Chief Information Officer

    Mr. Daniel Gesua Sive Salvadori

    Executive VP and Group President of Established Pharmaceuticals & Nutritional Products

    Ms. Melissa Brotz

    Senior Vice President of Global Marketing & External Affairs

    FAQs

    What is Abbott Laboratories share price today?

    Abbott Laboratories share price today is $103.97 as on at the close of the market. Abbott Laboratories share today touched a day high of $105.46 and a low of $103.68.

    What is the 52 week high and 52 week low for Abbott Laboratories share?

    Abbott Laboratories share touched a 52 week high of $139.06 on and a 52 week low of $102.41 on . Abbott Laboratories stock price today i.e. is closed at $103.97,which is 25.23% down from its 52 week high and 1.52% up from its 52 week low.

    What is Abbott Laboratories's market capitalisation today?

    Abbott Laboratories market capitalisation is $0.18T as on .

    How to invest in Abbott Laboratories Stock (ABT) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Abbott Laboratories on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abbott Laboratories Shares that will get you 0.0144 shares as per Abbott Laboratories share price of $103.97 per share as on March 28, 2026 at 1:29 am IST.

    What is the minimum amount required to buy Abbott Laboratories Stock (ABT) from India?

    Indian investors can start investing in Abbott Laboratories (ABT) shares with as little as ₹94.63 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹946.30 in Abbott Laboratories stock (as per the Rupee-Dollar exchange rate as on ). Based on Abbott Laboratories share’s latest price of $103.97 as on March 28, 2026 at 1:29 am IST, you will get 0.0962 shares of Abbott Laboratories. Learn more about fractional shares .

    What are the returns that Abbott Laboratories has given to Indian investors in the last 5 years?

    Abbott Laboratories stock has given -14.81% share price returns and 29.07% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?